You are leaving our website

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.


  • Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
  • Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
  • Privacy and security policies do not apply to third-party websites.
or Decline

ESG Committee

The members of the ESG Committee (the "Committee") are:

David Cook (Chairman of the Committee)
Richard Jones
Jo LeCouilliard
Peter Butterfield
Andrew Franklin

The Company Secretary, attends all the meetings of the Remuneration Committee. The Corporate Finance & Investor relations Manager and external advisors may be invited to attend to all or part of any meeting as and when appropriate.

Role of Committee

In accordance with its Terms of Reference, the ESG Committee reviews and recommends the overarching environmental, social & governance vision to the Board to ensure ESG priorities are anchored at the top of the Company and form an integral part of its corporate strategy.